Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab

Summary

This is a non-randomized phase II study of targeted radiotherapy (RT) administered concurrently with panitumumab in patients with locally advanced squamous carcinoma of the head and neck.

Timeline

Start

2011-12

Primary completion

2017-12

Completion

2018-12

Outcome

Outcome not reported

Stopped (Enrollment): “Funding source was terminated before enrollment of first subject”

Drugs

Indications